The European Commission has insisted it still trusts the coronavirus vaccine developed by AstraZeneca and that its dispute with the Anglo-Swedish pharmaceutical firm is only contractual.
The EU's executive branch has launched legal proceedings in Belgium against the firm for what it believes amounts to a breach of contract after AstraZeneca failed to deliver doses of its coronavirus vaccine in a timely manner.
Millions of doses of AstraZeneca have been safely administered in Europe, but concerns linger over a rare type of blood clot seen in an extremely small number of recipients.
The dispute between the EU and the company has further dented the public's confidence in the efficiency of the vaccine, but the European Commission insisted on Monday the AstraZeneca serum remains part of its strategy to have 70% of all EU adults immunised this summer.
"First of all, the AstraZeneca vaccine is a very important vaccine for our vaccine portfolio," said Stefan de Keersmaecker, the commission's health policy spokesman.
"Thousands of Europeans are currently receiving the vaccine and it is very much part of our vaccine mix at the moment."
Dr de Keersmaecker spoke after two senior EU officials over the weekend said the EU did not renew its order for the AstraZeneca vaccine beyond June and would not buy more doses in the future.
Dr de Keersmaecker confirmed that the commission did not exercise the option to buy an additional 100 million doses on the basis of the current agreement it sealed with the company.
"But I can't tell you about the future at this stage," he said.
READ MORE: European Commission launches legal action against AstraZeneca over vaccine contract
"What remains important is that we receive the delivery of the ordered doses."
AstraZeneca's contract with the EU, which was signed by the commission on behalf of the member countries last August, foresaw an initial 300 million doses for distribution among member countries, with an option for a further 100 million.
The British-Swedish firm had hoped to deliver 80 million doses of that in the first quarter of 2021, but only 30 million were sent.
According to the commission, the company is now set to provide 70 million doses in the second quarter, rather than the 180 million it had promised.
"What we are now doing in our court case before the Brussels court is to make sure that we can obtain the delivery of doses we are entitled to," Dr de Keersmaecker said.
The legal dispute has eroded the relationship between AstraZeneca and the EU, which reinforced its partnership with Pfizer/BioNTech last week by agreeing to a massive contract extension for a potential 1.8 billion doses of its vaccine through 2023.
The European Commission currently has a portfolio of 2.6 billion doses from half a dozen companies.
Why are you making commenting on The Herald only available to subscribers?
It should have been a safe space for informed debate, somewhere for readers to discuss issues around the biggest stories of the day, but all too often the below the line comments on most websites have become bogged down by off-topic discussions and abuse.
heraldscotland.com is tackling this problem by allowing only subscribers to comment.
We are doing this to improve the experience for our loyal readers and we believe it will reduce the ability of trolls and troublemakers, who occasionally find their way onto our site, to abuse our journalists and readers. We also hope it will help the comments section fulfil its promise as a part of Scotland's conversation with itself.
We are lucky at The Herald. We are read by an informed, educated readership who can add their knowledge and insights to our stories.
That is invaluable.
We are making the subscriber-only change to support our valued readers, who tell us they don't want the site cluttered up with irrelevant comments, untruths and abuse.
In the past, the journalist’s job was to collect and distribute information to the audience. Technology means that readers can shape a discussion. We look forward to hearing from you on heraldscotland.com
Comments & Moderation
Readers’ comments: You are personally liable for the content of any comments you upload to this website, so please act responsibly. We do not pre-moderate or monitor readers’ comments appearing on our websites, but we do post-moderate in response to complaints we receive or otherwise when a potential problem comes to our attention. You can make a complaint by using the ‘report this post’ link . We may then apply our discretion under the user terms to amend or delete comments.
Post moderation is undertaken full-time 9am-6pm on weekdays, and on a part-time basis outwith those hours.
Read the rules here